StonvexLoading…
StonvexStonvexStonvexCore line items from PTHS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $10.91M | $16.80M | $294.00K | $0.00 |
Operating Income | $-13.09M | $-32.43M | $-20.43M | $-1.83M |
Net Income | $-10.24M | $-43.32M | $-21.66M | $-1.97M |
EPS (Diluted) | $-3.09 | $-23.04 | $-14.96 | $-3.21 |
Total Assets | $145.38M | $130.40M | $126.43M | $911.18K |
Total Liabilities | $110.28M | $91.52M | $68.18M | $5.11M |
Cash & Equivalents | $31.98M | $17.97M | $14.20M | $131.00K |
Free Cash Flow OCF − CapEx | $-13.32M | $-22.69M | Not available | $-632.00K |
Shares Outstanding | 3.37M | 3.23M | 3.09M | 6.18M |